Citation Inadequacy Via Databanks

Any research paper that contained a reference list consisting only of the titles of the journals consulted and not their years of publication, volume and page numbers, and the names of the authors would surely be rejected out of hand by editor and referees alike. Right? Not so. Increasing numbers of papers are being submitted with references in precisely this form, and they are being accepted without question. The authors of the papers, the editors of the journals and the referees all seem unawa

Written byJohn Hodgson
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Not so. Increasing numbers of papers are being submitted with references in precisely this form, and they are being accepted without question. The authors of the papers, the editors of the journals and the referees all seem unaware that this is taking place. And the probable explanation for this is that the data being cited are contained not in the pages of learned journals, but in the files of certain scientific databanks. Authors are acknowledging the databanks, but not citing the workers who originally deposited the data. Unless this problem is resolved soon, those currently depositing the data may become reluctant to do so.

It could be argued that scientists funded by the public purse should make their findings publicly available and should not expect any reward beyond that of knowing that they are serving science. Unfortunately, science is not structured to encourage this altruistic attitude. A convoluted mechanism has ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies